Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. INDP
INDP logo

INDP

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

INDP News

uniQure Shares Surge After FDA Softens Stance on Gene Therapy

Jun 18 2026NASDAQ.COM

Investigation into Indaptus Therapeutics Shareholder Claims

Jun 18 2026Globenewswire

Biotech Stocks Show Significant Pre-Market Movements

Jun 05 2026NASDAQ.COM

Biotech Stocks Surge with Akari Leading the Rally

May 26 2026NASDAQ.COM

Indaptus Therapeutics Q1 Financial Analysis

May 15 2026seekingalpha

Indaptus Therapeutics Enters $6 Million Securities Purchase Agreement with David E. Lazar

Dec 29 2025Globenewswire

Indaptus Therapeutics Enters $6 Million Securities Purchase Agreement with David E. Lazar

Dec 29 2025Newsfilter

Multi Ways Holdings Reports 87.65% Revenue Growth to $26.44 Million in H1 2025

Dec 24 2025Benzinga

Indaptus Therapeutics Completes Board Restructuring and Raises $6 Million

Dec 24 2025Benzinga

Indaptus Therapeutics Stock Soars 64.65% to $3.26 After Securities Agreement

Dec 24 2025Benzinga

Indaptus Therapeutics Announces Reverse Stock Split

Jun 25 2025Newsfilter

Indaptus Therapeutics Sets 1-for-28 Reverse Stock Split

Jun 25 2025NASDAQ.COM

3 Penny Stocks to Watch Now, 6/24/25

Jun 24 2025TipRanks

Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices

Jun 24 2025PRnewswire

Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results

Jun 23 2025Benzinga

Why Sequans Communications Shares Are Trading Higher By Over 42%; Here Are 20 Stocks Moving Premarket

Jun 23 2025Benzinga